Safety and Electrical Performances of XFINE Leads

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

Also called NCT03922386

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 188 participants (enrolled count) (from the registry)
Sponsor
  • MicroPort CRM Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03922386
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Italy, Portugal, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03922386. Non-randomized; no masking; primary purpose other. Start 2019-09-09 (actual); primary completion 2021-03-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Electrical Performances of XFINE Leads
Acronym
PERSEPOLIS
Condition
Bradycardia
Intervention (Device)
XFINE leads
Lead sponsor
MicroPort CRM (class: industry)

Record details

Record id
cardio:ct-nct03922386
Content hash
da7358307c0ecf6bc1205712f5c0f7556d77620642f0bf741d0b48bd902293f4